Evaluate the Safety, Tolerability and Pharmacokinetics of BG00010 (Neublastin) Administered to Sciatica Participants

NCT00961766 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Sciatica

Interventions

DRUG: BG00010 (Neublastin)
DRUG: Placebo

Sponsor

Biogen